AGY.L

Allergy Therapeutics plc [AGY.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

AGY.L Stock Summary

Top 10 Correlated ETFs

AGY.L


Top 10 Correlated Stocks

AGY.L


In the News

AGY.L Financial details

Company Rating
Neutral
Market Cap
130.84M
Income
-56.85M
Revenue
132.36M
Book val./share
0
Cash/share
0.01
Dividend
-
Dividend %
-
Employees
612
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-0.36
Forward P/E
-300
PEG
-0.01
P/S
2.11
P/B
-3.83
P/C
300
P/FCF
-3.73
Quick Ratio
0.78
Current Ratio
1.8
Debt / Equity
13.67
LT Debt / Equity
12.8
-
-
EPS (TTM)
-0.06
EPS next Y
-0.01
EPS next Q
-
EPS this Y
198.99%
EPS next Y
-83.71%
EPS next 5Y
-116.29%
EPS last 5Y
NAN%
Revenue last 5Y
-4.17%
Revenue Q/Q
-50.66%
EPS Q/Q
296.61%
-
-
-
-
SMA20
9.41%
SMA50
13850%
SMA100
96.48%
Inst Own
0%
Inst Trans
0%
ROA
-75%
ROE
79%
ROC
-0.68%
Gross Margin
57%
Oper. Margin
-55%
Profit Margin
-84%
Payout
-
Shs Outstand
4.77B
Shs Float
159.68M
-
-
-
-
Target Price
-
52W Range
0.8-6.25
52W High
-
52W Low
-
RSI
71.33
Rel Volume
0.18
Avg Volume
658.43K
Volume
120.4K
Perf Week
9.09%
Perf Month
25%
Perf Quarter
100%
Perf Half Y
150%
-
-
-
-
Beta
1.308
-
-
Volatility
0.12%, 0.15%
Prev Close
0%
Price
3
Change
7.14%

AGY.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-06-30

Metric History 2019-06-302020-06-302021-06-302022-06-30 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.110.050.060.050.04
Net income per share
0.0100-0.01-0.03
Operating cash flow per share
0.010.010.01-0.01-0.02
Free cash flow per share
00.010-0.01-0.02
Cash per share
0.040.030.030.010.01
Book value per share
0.060.030.030.030
Tangible book value per share
0.050.020.030.020
Share holders equity per share
0.060.030.030.030
Interest debt per share
00000.02
Market cap
42.2M94.22M169.19M133.4M7.04M
Enterprise value
17.2M69.44M140.09M123.41M28.18M
P/E ratio
12.1713.3558.63-9.68-0.16
Price to sales ratio
0.571.22.011.830.12
POCF ratio
7.547.6819.87-9.45-0.23
PFCF ratio
15.139.6828.42-7.77-0.2
P/B Ratio
1.122.153.493.533.41
PTB ratio
1.122.153.493.533.41
EV to sales
0.230.891.661.70.47
Enterprise value over EBITDA
-17.2K8.320.68-13.97-0.92
EV to operating cash flow
3.075.6616.45-8.75-0.91
EV to free cash flow
6.167.1423.53-7.19-0.79
Earnings yield
0.080.070.02-0.1-6.12
Free cash flow yield
0.070.10.04-0.13-5.06
Debt to equity
0.060.120.090.113.67
Debt to assets
0.040.060.050.050.42
Net debt to EBITDA
25K-2.96-4.31.13-0.69
Current ratio
2.773.033.172.351.81
Interest coverage
-166.9113.156.85-24.03-16.15
Income quality
1.621.742.951.020.72
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.240.250.250.290.42
Research and developement to revenue
0.090.120.150.220.34
Intangibles to total assets
0.070.10.090.110.12
Capex to operating cash flow
-0.5-0.21-0.30.220.15
Capex to revenue
-0.04-0.03-0.03-0.04-0.08
Capex to depreciation
-1.53-0.65-0.62-0.73-1.11
Stock based compensation to revenue
0.020.010.010.010
Graham number
0.080.060.040.080.03
ROIC
-0.040.080.04-0.28-0.93
Return on tangible assets
0.050.090.04-0.21-0.73
Graham Net
0.0100.010-0.03
Working capital
29.77M36.94M39.63M24.34M14.96M
Tangible asset value
32.72M35.58M40.44M29.38M-5.68M
Net current asset value
15.69M12.73M18.3M7.21M-31.18M
Invested capital
0.060.120.090.113.67
Average receivables
4.16M6.28M7.15M8.35M8.78M
Average payables
3.67M3.18M2.56M3.59M4.19M
Average inventory
9.11M9.77M10.49M11.12M11.5M
Days sales outstanding
22.2437.6926.9352.5143.42
Days payables outstanding
82.2439.1146.9365.6355.5
Days of inventory on hand
186.86178.74175.56174.88157.33
Receivables turnover
16.419.6813.556.958.41
Payables turnover
4.449.337.785.566.58
Inventory turnover
1.952.042.082.092.32
ROE
0.090.160.06-0.36-20.85
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q4

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.020.030.040.030.01
Net income per share
-0.010-0.03-0.01-0.02
Operating cash flow per share
00-0.03-0.01-0.02
Free cash flow per share
00-0.03-0.01-0.02
Cash per share
0.030.030.030.010.01
Book value per share
0.030.040.060.030
Tangible book value per share
0.030.030.050.020
Share holders equity per share
0.030.040.060.030
Interest debt per share
000.0100.02
Market cap
160.47M221.35M61.52M41.39M7.13M
Enterprise value
131.37M189.89M51.53M35.97M28.27M
P/E ratio
-3.338.3-0.75-1.22-0.05
Price to sales ratio
5.34.552.561.040.36
POCF ratio
-37.2659.63-3.49-5.47-0.31
PFCF ratio
-2686.3-3.15-3.96-0.28
P/B Ratio
3.314.031.61.093.45
PTB ratio
3.314.031.61.093.45
EV to sales
4.343.92.140.91.44
Enterprise value over EBITDA
-19.519.85-2.8-6.3-1.09
EV to operating cash flow
-30.551.16-2.92-4.75-1.21
EV to free cash flow
-21.2974.03-2.64-3.44-1.13
Earnings yield
-0.080.03-0.33-0.21-4.85
Free cash flow yield
-0.040.01-0.32-0.25-3.52
Debt to equity
0.090.060.10.0813.67
Debt to assets
0.050.040.050.040.42
Net debt to EBITDA
4.32-3.290.540.95-0.82
Current ratio
3.173.82.352.221.81
Interest coverage
-35.4835.13-43.34-19.64-13.68
Income quality
0.360.560.860.890.68
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.360.220.420.30.68
Research and developement to revenue
0.160.10.440.210.59
Intangibles to total assets
0.090.080.110.110.12
Capex to operating cash flow
0.43-0.310.110.380.08
Capex to revenue
-0.06-0.02-0.08-0.07-0.09
Capex to depreciation
-0.89-0.48-1.08-1.37-0.84
Stock based compensation to revenue
0.020.010.0100
Graham number
0.080.060.210.060.03
ROIC
-0.150.1-0.42-0.17-0.76
Return on tangible assets
-0.150.08-0.31-0.13-0.59
Graham Net
0.010.0100-0.03
Working capital
39.63M46.49M24.34M20.81M14.96M
Tangible asset value
40.44M47.44M30.02M29.94M-5.68M
Net current asset value
18.3M26.09M7.21M4.21M-31.18M
Invested capital
0.090.060.10.0813.67
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
18.4819.9139.1426.3832.4
Days payables outstanding
143.71105.18134.6191.15122.83
Days of inventory on hand
94.5474.6398.0269.9485.35
Receivables turnover
4.874.522.33.412.78
Payables turnover
0.630.860.670.990.73
Inventory turnover
0.951.210.921.291.05
ROE
-0.250.12-0.53-0.22-16.73
Capex per share
00000

AGY.L Frequently Asked Questions

What is Allergy Therapeutics plc stock symbol ?

Allergy Therapeutics plc is a GB stock and trading under the symbol AGY.L

What is Allergy Therapeutics plc stock quote today ?

Allergy Therapeutics plc stock price is $3 today.

Is Allergy Therapeutics plc stock public?

Yes, Allergy Therapeutics plc is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap